These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1427576)

  • 1. Medical treatment of reflux esophagitis.
    Olbe L; Lundell L
    Hepatogastroenterology; 1992 Aug; 39(4):322-4. PubMed ID: 1427576
    [No Abstract]   [Full Text] [Related]  

  • 2. Omeprazole therapy in resistant reflux disease.
    Waldum HL; Brenna E
    Ann Intern Med; 1995 Feb; 122(3):236; author reply 236-7. PubMed ID: 7888009
    [No Abstract]   [Full Text] [Related]  

  • 3. Omeprazole therapy in resistant reflux disease.
    Wright JM; Sarich TC
    Ann Intern Med; 1995 Feb; 122(3):236; author reply 236-7. PubMed ID: 7810947
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comment on the contribution: "Effect of omeprazole on serum gastrin levels: influence of age and sex" by Koop et al].
    Miederer SE
    Z Gastroenterol; 1991 Apr; 29(4):177-8. PubMed ID: 1866976
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of omeprazole on serum gastrin levels: influence of age and sex.
    Koop H; Naumann-Koch C; Arnold R
    Z Gastroenterol; 1990 Nov; 28(11):603-5. PubMed ID: 1981116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment of severe reflux esophagitis with omeprazole: a therapeutic success?].
    Müller-Lissner S
    Z Gastroenterol; 1989 Feb; 27(2):131-2. PubMed ID: 2658391
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM
    Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.
    Koop H; Arnold R
    Dig Dis Sci; 1991 May; 36(5):552-7. PubMed ID: 1673654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole.
    Cheung G
    Conn Med; 1990 Jul; 54(7):392-3. PubMed ID: 2394098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Haber M
    Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflux esophagitis: healed! Now what?
    Romero Y; Egan LJ; Murray JA
    Am J Gastroenterol; 2000 Feb; 95(2):337-8. PubMed ID: 10685730
    [No Abstract]   [Full Text] [Related]  

  • 15. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis].
    Lauritsen K; Laursen LS; Madsen JR
    Ugeskr Laeger; 1989 Jul; 151(28):1831-3. PubMed ID: 2773093
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
    Ladas SD; Tassios PS; Raptis SA
    Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole, hypergastrinemia, and gastric carcinoid tumors.
    Freston JW
    Ann Intern Med; 1994 Aug; 121(3):232-3. PubMed ID: 8017751
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing concerns about chronic proton pump inhibitor use.
    Svoboda AC
    J Clin Gastroenterol; 2001 Jul; 33(1):3-7. PubMed ID: 11418781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.